Category: 15. Heart Failure: Clinical
Background: Small studies have found hemoconcentration associated with improved outcomes in hospitalized heart failure (HHF) patients (pts). We investigated the patient characteristics and outcomes associated with in-hospital changes in hematocrit in a large cohort of HHF pts with ejection fraction (EF) ≤40%. methods: In 1,684 pts assigned to the placebo arm of the EVEREST trial with available data, in-hospital hematocrit change was calculated as the difference between baseline and discharge or day-7 hematocrit (whichever occurred first).
results: Hemoconcentration correlated with in-hospital increases in serum creatinine and urea nitrogen levels and in-hospital decreases in glomerular filtration rate and body weight. Over median follow-up of 9.9 months, every 5% increase of in-hospital hematocrit change was associated with a decreased risk of all-cause death (Hazard Ratio [HR] = 0.79, 95% Confidence Interval [CI]0.68-0.90) and the composite of cardiovascular mortality or heart failure (HF) hospitalization (HR = 0.87, 95% CI 0.78-0.97).
conclusion: In this large cohort of HHF pts with reduced EF, hemoconcentration was associated with decreased mortality and HF hospitalization despite an increased risk of worsening renal function. aValues expressed as mean +/-SD, median (25th -75th percentile) or n (%) bDefined as increase in creatinine ≥0.3 mg/dl cDefined as ≥25% increase dDefined as ≥25% decrease
